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Tricuspid Prostheses
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c aortA 53-year-old woman presented to our center with
progressive fatigue and dyspnea on exertion (New
York Heart Association functional class III). The
patient’s medical history was significant for multi-
ple cardiac interventions: open mitral commissur-
otomy for the treatment of rheumatic mitral ste-
nosis 30 years earlier, mitral valve replacement for
the treatment of severe mitral regurgitation at age
25 years, and tricuspid valve implantation for the
treatment of rheumatic tricuspid valve regurgita-
tion and stenosis 5 years earlier. She had also
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Figure 1. Fluoroscopy Before and After TAVI
Fluoroscopic images (A) before and (B) after transfemoral aortic v
and mitral prosthesis (asterisk). The arrow indicates the prosthetiManuscript received June 4, 2012; accepted June 21, 2012.undergone several noncardiac surgeries: trauma-
related splenectomy 30 years earlier, partial menis-
cectomy 27 years ago, tibial external fixation 10
years ago, and Billroth II procedure for the treat-
ment of peptic ulcer 5 years ago. At the time of
presentation, she was also under medical treatment
for hypothyroidism and depression.
Transesophageal echocardiographic (TEE) as-
sessment revealed severe aortic stenosis (mean
systolic gradient: 47 mm Hg; peak gradient: 98
mm Hg; aortic valve area: 0.7 cm2; valve annulus:
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eployment depicting the prosthetic tricuspid valve (arrowhead)
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e3020 mm), moderate aortic regurgitation, functionally normal
mitral and tricuspid prosthetic valves, severe pulmonary
hypertension (mean pulmonary artery pressure: 68 mm Hg),
and moderately reduced left ventricular function (ejection
fraction: 35%). Selective coronary angiogram revealed nor-
mal coronaries.
Due to excessive surgical risk with conventional aortic
valve replacement (logistic EuroSCORE of 15.23%), the
patients was scheduled for transfemoral transcatheter aortic
valve implantation. The procedure was performed under
general anesthesia and as previously described (1). Briefly,
after aortography, balloon valvuloplasty of the native aortic
valve was performed under rapid ventricular pacing, and
subsequently, a 23-mm Edwards SAPIEN aortic valve (Ed-
wards Lifesciences, Irvine, California) was implanted at the
aortic annulus (Fig. 1). The procedure was performed without
any complications, and post-procedure and pre-discharge TEE
revealed normal aortic prosthetic valve function (peak gradient:
12 mm Hg; aortic valve area: 2.2 cm2) with no residual aorticaravalvular leaks. The patient was discharged on post-
rocedural day 5; her in-hospital stay had been uneventful.
At 6-month and 1-year follow-up, echocardiographic
valuation revealed normal left ventricular function (ejection
raction: 55%) and the appropriate position and normal
unction of all 3 prosthetic valves. At these times, she was
ymptom free and was in New York Heart Association
unctional class I.
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